Addressing complications after lung resection: evolution from experience, innovation through adversity Authors: Andrei I Gritsiuta, Roman V Petrov Published: 2026 Anatomical lung resection remains the cornerstone of curative therapy for early-stage non-small cell lung cancer and select group of complex benign pulmonary pathology. Procedures such as segmentectomy, lobectomy, and pneumonectomy represent operations of increasing physiologic impact performed in a patient population already plagued by an advanced age, tobacco exposure, and significant cardiopulmonary comorbidity. Although the field has witnessed remarkable advances with the adoption of minimally invasive technologies, enhanced recovery pathways, and increasingly sophisticated anesthetic and perioperative care, postoperative complications continue to shape the clinical course of many patients undergoing lung resection (1-3). In this context, technical proficiency alone is no longer sufficient. Modern thoracic surgical practice requires a comprehensive understanding of the complication landscape, including the ability to anticipate adverse events, stratify patient-specific risk, implement targeted preventive measures, and operate within systems designed to recognize deterioration early and ensure timely rescue. Epidemiology of postoperative morbidity Complications after lung resection remain common and clinically consequential. Large registry analyses consistently demonstrate that postoperative morbidity affects a substantial proportion of patients undergoing anatomical lung resection (4-6). Contemporary national data indicate that approximately one quarter of patients experience at least one postoperative complication (6). In an analysis of more than 32,000 anatomic lung resections performed across the United States, 15.8% of patients developed at least one in-hospital complication, with a median length of stay of 4 days in uncomplicated cases compared with 8 days when complications occurred, highlighting the immediate clinical and system-level impact of adverse events (5). These findings reinforce an important principle: complications after lung resection should not be viewed as isolated or unexpected occurrences, but rather as predictable events within a physiologically vulnerable surgical population. The incidence and severity of postoperative complications also vary substantially according to the extent of pulmonary resection. Among anatomical resections, bilobectomy carries the highest overall complication rate, reported at approximately 66%, followed by pneumonectomy at nearly 55% (6). Although overall morbidity rates are relatively similar between pneumonectomy and lobectomy, major complications, their magnitude, and mortality are significantly more frequent following pneumonectomy. Major complications occur in approximately 21% of pneumonectomy patients compared with 13% after lobectomy, while 90-day mortality is markedly higher at 6.9% vs. 1.9% (7). In contrast, sublobar resections such as wedge resections are associated with the lowest complication rates, reflecting their diminished physiologic impact. Both patient-specific and procedural factors contribute to postoperative risk. Several clinical characteristics have consistently been associated with increased morbidity after lung resection, including male sex, advanced age (65 years or older), chronic obstructive pulmonary disease, asthma, low body mass index (below 21 kg/m2), and poor nutritional status reflected by a prognostic nutritional index below 45 (8). Additional comorbid conditions such as preexisting vascular disease, insulin-dependent diabetes, and a high preoperative risk profile, including an ASA class III or greater, further increase the likelihood of postoperative complications. Procedural characteristics likewise carry a significant impact on outcomes. Upper lobe resections, prolonged operative duration exceeding approximately 2.5 hours, and the need for postoperative mechanical ventilation are among the operative factors associated with increased postoperative morbidity (8). Among all postoperative events, respiratory complications exert the greatest influence on postoperative mortality, exceeding that of cardiac complications (6). Beyond their immediate impact, pulmonary complications significantly alter the postoperative course. Patients who develop respiratory morbidity experience markedly prolonged hospitalizations of nearly 9 additional days, significantly higher rates of intensive care unit admission, and reduced long-term survival (6). The long-term implications of postoperative morbidity are particularly evident following pneumonectomy. Patients undergoing pneumonectomy experience substantially higher nononcologic mortality in the years following surgery compared with those undergoing lobectomy, with deaths frequently attributable to pneumonia and myocardial infarction rather than cancer recurrence (7). Moreover, the occurrence of a postoperative pulmonary complication has been shown to independently predict late mortality among patients with non-small cell lung cancer (9). These observations highlight that complications after lung resection do not merely influence early outcomes and mortality but may have long-lasting impact on the outcomes as well. Contemporary analyses increasingly move beyond binary definitions of prolonged length of stay and instead quantify the discrete, risk-adjusted increase in hospitalization attributable to individual complications (10). In a national analysis adjusting for 27 preoperative characteristics and 18 concurrent postoperative events using negative binomial modeling, nearly every complication independently prolonged hospitalization (5). Prolonged mechanical ventilation was associated with an increase in hospital stay of 17.4 days, septic shock with 17.2 days, and acute renal failure with 16.5 days. Deep surgical site infection extended hospitalization by 13.2 days, while pneumonia added nearly 8 additional days. Moreover, events generally considered routine, such as perioperative transfusion, increased length of stay by approximately 2.6 days (5). These findings illustrate that complications do not simply lengthen recovery in incremental fashion but represent major inflection points that fundamentally alter postoperative trajectory. Such observations invite a broader reframing of complication science in thoracic surgery. In large national analyses, comorbid conditions such as chronic obstructive pulmonary disease, baseline dyspnea, dialysis dependence, active smoking, and low body mass index have been independently associated with prolonged hospitalization (5). These factors define physiologic reserve and susceptibility to perioperative stress. More granular complication-specific modeling provides additional insight into the mechanisms through which this vulnerability manifests. Postoperative prolonged air leak, occurring in approximately 12.3% of patients, has been independently associated with low body mass index, thoracoscopic approach, and prolonged operative duration. Atelectasis is more frequently observed in patients with chronic obstructive pulmonary disease and asthma, reflecting impaired pulmonary mechanics and airway clearance. Postoperative arrhythmia, in contrast, has been linked to poor nutritional status reflected by a low prognostic nutritional index, more extensive resections such as lobectomy or greater, and operative times exceeding 155 minutes (8). These associations underscore the multifactorial nature of postoperative morbidity and highlight modifiable domains including operative efficiency, nutritional optimization, and pulmonary conditioning. Yet even when these baseline risk factors are present, their influence on postoperative recovery remains modest when compared with the impact of complications themselves. Patient physiology establishes the underlying vulnerability, but it is the development of complications that ultimately determines the clinical course, the intensity of postoperative care, and the duration of recovery. Procedure selection itself meaningfully shapes the landscape of postoperative risk. Data from the national ACS NSQIP cohort demonstrates a clear gradient in recovery following different extents of pulmonary resection, with a median length of stay of 3 days after segmentectomy, 5 days after lobectomy, and 6 days after pneumonectomy (5). These differences reflect more than operative preference; they illustrate the physiologic consequences of parenchymal sacrifice, highlighting that oncological appropriate, parenchymal-preserving strategies may lessen the physiologic burden of surgery and reduce baseline vulnerability to postoperative complications. At the same time, operative duration remains an independent predictor of severe morbidity, reminding us that technical execution carries consequences beyond the operating room (8). Efficiency in thoracic surgery should not be interpreted simply as speed, but rather as disciplined operative conduct that minimizes tissue trauma, limits physiological stress, and ultimately mitigates risk. Clinical spectrum and management of complications The spectrum of postoperative morbidity is broad. Overall complication rates approach 28%, with respiratory complications representing the most frequent category, followed by cardiac and thromboembolic events (6). Respiratory insufficiency and prolonged air leak are among the most common complications, occurring in approximately 8% of patients, while pneumonia, atelectasis, and postoperative arrhythmias also contribute significantly to postoperative morbidity. Additional complications such as postoperative bleeding, pulmonary edema, bronchopleural fistula, empyema, and venous thromboembolism further contribute to the complexity of postoperative care (6). Although less frequent, several complications stemming from technical error carry particularly severe consequences, including cardiac herniation, lung torsion, and chylothorax (11). Respiratory morbidity continues to represent the dominant threat following lung resection and remains the principal driver of early postoperative decline (12). Atelectasis is nearly universal in the immediate postoperative period and frequently serves as the physiologic substrate from which more serious complications such as pneumonia and respiratory failure arise. Consequently, fundamental perioperative practices such as early mobilization, aggressive pulmonary toilet, effective analgesia, and meticulous fluid management should be viewed not as ancillary measures but as cornerstone components of complication prevention. When pneumonia develops, prompt clinical evaluation and early initiation of empiric antimicrobial therapy directed toward hospital-acquired pathogens are essential. Similarly, hypoxemic respiratory failure, typically defined by a partial pressure of oxygen (PaO2) below 60 mmHg or oxygen saturation below 90% on room air, requires rapid identification of reversible causes, including pleural effusion, pneumothorax, atelectasis, and volume overload. When ventilatory support becomes necessary, lung protective strategies employing low tidal volumes and appropriate positive end-expiratory pressure are critical to minimize additional pulmonary injury. Particular caution is warranted after pneumonectomy, where excessive fluid administration remains a well-recognized precipitant of postresection pulmonary edema and must be rigorously avoided. Management of postoperative air leak illustrates the delicate balance between operative precision and postoperative clinical judgment (12). Prolonged air leak, commonly defined as persistence for more than 5 to 7 postoperative days, most frequently reflects an alveolar pleural fistula rather than a bronchopleural fistula. In many cases, conservative strategies such as optimized chest tube management, ambulatory one-way valve systems, autologous blood patch, intrapleural administration of sclerosing agents, or endobronchial valves provide effective resolution. However, the clinician must remain vigilant, as failure to distinguish a benign postoperative air space from an evolving bronchopleural fistula may delay timely intervention and allow progression to life-threatening infection. Bronchopleural fistula and empyema remain among the most feared complications in thoracic surgery (12). In the postpneumonectomy setting, an unexpected decline in the air-fluid level on chest radiography should immediately raise suspicion and prompt diagnostic bronchoscopy. Early detection permits prompt intervention, including direct bronchial stump repair or reinforcement with vascularized tissue (13). Delayed recognition may necessitate more extensive salvage procedures such as open window thoracostomy, use of muscle flap, and other strategies of pleural space management. Similarly, the management of empyema requires timely drainage, targeted antimicrobial therapy, and careful evaluation for an associated bronchopleural fistula and entrapped lung. These complications challenge not only surgical technique but also the coordination and responsiveness of the entire perioperative care system. Cardiovascular complications carry comparable clinical significance. Postoperative atrial fibrillation occurs in more than 15% of patients undergoing major thoracic surgery and represents the most common cardiac event in this setting (12). Management typically follows structured algorithms beginning with rate control using beta blockers or calcium channel blockers, with escalation to antiarrhythmic therapy such as amiodarone when necessary. Electrical cardioversion is reserved for patients with hemodynamic instability. When atrial fibrillation persists beyond 48 hours, stroke risk assessment and consideration of anticoagulation become essential components of management. Thromboembolic events similarly demand vigilant prophylaxis through routine pharmacologic thromboprophylaxis, early ambulation, and use of sequential compression devices, and likewise require rapid diagnostic evaluation when clinical suspicion arises. Pain control represents another critical interface between postoperative care and complication prevention. Inadequate analgesia limits effective pulmonary mechanics, airway clearance, and early mobilization, thereby predisposing patients to pulmonary complications. On the contrary, excessive narcotic use can lead to altered level of consciousness and oversedation negatively affecting postoperative mobilization and increasing the risk of aspiration, leading to rise in postoperative complications. Multimodal analgesic strategies incorporating acetaminophen, nonsteroidal anti-inflammatory agents, neuromodulators, and regional anesthetic techniques have demonstrated meaningful effects on postoperative recovery. In this context, pain management should not be viewed merely as a comfort measure but rather as a central pillar of streamlined postoperative recovery and complication prevention. Systems-based prevention and rescue Complications after lung resection should not be viewed solely through a clinical lens. They are also powerful drivers of health care resource utilization (14). Surgical care accounts for a substantial proportion of inpatient expenditure, and postoperative morbidity remains the principal driver of cost escalation (15). Modern analyses that quantify the discrete impact of individual complications on length of stay provide important insight into this relationship (16). A complication that prolongs hospitalization by 2 days carries a fundamentally different systems burden than one that extends recovery by 2 weeks. Understanding this gradient allows institutions to prioritize prevention strategies according to both incidence and downstream impact. The evolution of thoracic surgery has long been shaped by innovation in surgical technique and perioperative management. Yet improvements in outcomes have been driven equally by disciplined examination of complications and their consequences. The concept of “Failure to Rescue” has underscored that survival after major surgery depends not only on the occurrence of complications but also on the capacity of a system to recognize deterioration early and intervene effectively. Institutional responsiveness, structured escalation pathways, and multidisciplinary coordination are therefore as critical to outcomes as operative technique itself. In this context, the management of complications after lung resection must extend beyond the operating room and span across several interconnected domains. First, patient optimization remains foundational in prophylaxis of complications and includes pulmonary prehabilitation, smoking cessation, nutritional support, and meticulous management of preexistent comorbidities. Second, operative precision is essential to minimize tissue trauma, reduce air leak, limit transfusion, and avoid unreasonable extension of operative time. Third, standardized postoperative pathways emphasizing early mobilization, multimodal analgesia, judicious fluid management, arrhythmia surveillance, and structured pulmonary care provide the framework for complication prevention and early detection. Finally, resilient systems of care must ensure rapid recognition of clinical deterioration, effective multidisciplinary collaboration, and timely intervention when complications occur. Complications after anatomical lung resection should therefore be understood not as unfortunate aberrations but as biologically predictable responses to surgical stress in a vulnerable population. When approached through this lens, each complication becomes an opportunity to refine risk assessment, improve preventive strategies, and strengthen institutional systems of rescue. Experience sharpens anticipation. Data illuminate consequence. Innovation refines prevention. Systems science ensures rescue. This series “Complications in Anatomical Lung Resection: A Comprehensive Surgical Perspective” aims to synthesize operative expertise, individualized risk modeling, quantitative systems analysis, and evidence-based management strategies into a unified framework. By examining complications openly rather than avoiding them, and by translating observational data into practical clinical insight, we hope to transform adversity into progress and contribute to the continued evolution of thoracic surgical care. Supplementary The article’s supplementary files as Acknowledgments None. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Footnotes Provenance and Peer Review: This article was commissioned by the editorial office, Journal of Thoracic Disease for the series “Complications in Anatomical Lung Resection: A Comprehensive Surgical Perspective”. The article did not undergo external peer review. Funding: None. Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2026-0679/coif). The series “Complications in Anatomical Lung Resection: A Comprehensive Surgical Perspective” was commissioned by the editorial office without any funding or sponsorship. A.I.G. and R.V.P. served as the unpaid Guest Editors of the series. The authors have no other conflicts of interest to declare. References Associated Data Supplementary Materials The article’s supplementary files as